Related Experiment Videos
Leukocyte migration: dismantling inhibition.
1Program in Microbial Pathogenesis and Host Defense, University of California-San Francisco, Campus Box 2140, 600 16th Street, San Francisco, CA 94123, USA. ebrown@medicine.ucsf.edu
Trends in Cell Biology
|June 29, 2005
Summary
Src-family kinases Fgr and Hck normally inhibit immune cell signaling by phosphorylating PIR-B. This study reveals their crucial role in maintaining tonic inhibition, essential for chemokine receptor responses.
Area of Science:
- Immunology
- Cell Signaling
- Molecular Biology
Background:
- Chemokine signaling regulates immune cell function.
- Src-family kinases (SFKs) are critical regulators of cellular processes.
- PIR-B is an inhibitory receptor on leukocytes.
Purpose of the Study:
- To investigate the role of Fgr and Hck in regulating chemokine signaling.
- To elucidate the mechanism by which SFKs control leukocyte activation.
- To understand the function of PIR-B phosphorylation in immune responses.
Main Methods:
- Analysis of Fgr/Hck-deficient cells.
- Assessment of PIR-B phosphorylation levels.
- Study of chemokine-induced signaling pathways.
- Investigation of G-protein-coupled receptor (GPCR) ligand effects.
Main Results:
- Fgr and Hck were found to inhibit chemokine signaling in polymorphonuclear leukocytes and dendritic cells.
- PIR-B phosphorylation by Fgr/Hck is essential for tonic inhibition of cell activation.
- Chemokines transiently decrease PIR-B phosphorylation in resting cells.
- Fgr/Hck deficiency leads to reduced constitutive PIR-B phosphorylation.
Conclusions:
- Src-family kinases Fgr and Hck play a novel role in the tonic inhibition of leukocyte activation.
- Overcoming this SFK-mediated inhibition is necessary for effective chemokine signaling.
- These findings provide new insights into the regulation of immune cell responses.